July 2023 - Page 16 of 17

ThursdayJul 06, 2023 9:00 am

Genprex, Inc. (NASDAQ: GNPX) Receives Third Fast Track Designation for REQORSA(R), Setting Stage for Commencement of Acclaim-3 Clinical Trial in Q3

Genprex recently received a Fast Track Designation (“FTD”) from the FDA for its REQORSA(R) Immunogene Therapy in combination with Genentech, Inc.’s Tecentriq(R) in patients with extensive-stage small cell lung cancer This is Genprex’s third FTD and sets the stage for the initiation of its third lung cancer clinical trial, Acclaim-3 Acclaim-3 clinical trial is a Phase 1/2 dose escalation and clinical response study of maintenance therapy evaluating REQORSA in combination with Tecentriq The company expects to enroll the first patient in its Acclaim-3 clinical trial in the third quarter of 2023 Genprex is combining its lead product candidate, REQORSA, with…

WednesdayJul 05, 2023 2:03 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Regains Compliance with NYSE Listing Rule

D-Wave (NYSE: QBTS), a leader in commercial quantum computing systems, software and services, today announced that it has regained compliance with the New York Stock Exchange, meeting its continued listing standard for minimum share price. On July 3, 2023, the NYSE provided D-Wave with a notification letter of re-compliance based on D-Wave‘s share price being at least $1.00 on June 30, 2023, as well as a calculation of the company’s average closing price for the 30 trading days ended June 30, 2023, reflecting an average closing price above the NYSE’s $1.00 minimum requirement. D-Wave will continue trading on the NYSE,…

WednesdayJul 05, 2023 1:52 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in July’s Virtual Investor Summer Spotlight Series

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in the Virtual Investor Summer Spotlight Series. Company CEO John Climaco and chief medical officer Sandra L. Silberman will both be participating on a live webcast scheduled for July 11, 2023, at 12 p.m. ET. The live event will be streamed on the company’s event’s page, and a replay of the webcast will be available later that day and will be accessible for 90 days, also on the company website. To…

WednesdayJul 05, 2023 11:23 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Retains Law Firm to Actively Investigate, Combat Naked Short Selling Activities

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has retained Christian Attar, formally known as Christian Levine Law Group, and in partnership with Warshaw, Burstein, LLP, to combat naked short selling activities. Based on reports from ShareIntel, Mullen believes it may have been the target of a market manipulation scheme involving illegal naked short selling of its common stock and has decided to investigate and expose any potential wrongdoing. According to various publicly disclosed sources, Christian Attar, in partnership with Warshaw Burstein, LLP, have successfully prosecuted and collected millions of dollars in aggregate damages…

WednesdayJul 05, 2023 10:48 am

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Affirms Exceptional Quality of Graphite Material at Ruby Property

Reflex (CSE:RFLX) (OTCQB: RFLXF) (FSE: HF2) today announced that purities of 99.999% graphitic carbon (“Cg”) were obtained from preliminary metallurgical studies testing the purification of the material sourced from its flagship Ruby Graphite Project located near Dillon, Montana, USA. According to the update, graphite concentrations of 99.999% Cg purity were achieved solely using a conventional thermal purification process. “Today marks another major milestone for Reflex. The achievement of 99.999% Cg from purification testing - without any optimization - only reaffirms our belief in the exceptional quality of the graphite material hosted on our Ruby property,” said Reflex CEO Paul Gorman.…

WednesdayJul 05, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Contract Renewal Indicates Company’s Success in Supporting International Transports

Freight Technologies (aka Fr8Tech) has developed a technology solution that uses machine learning and artificial intelligence (“AI”) to help shipping and freighting companies optimize product transports and avoid costly errors Fr8Tech recently announced that one of its top clients, multinational insulation manufacturing company K-FLEX de México SA de CV, renewed its contract for using Fr8Tech’s core tech solution, Fr8App K-FLEX cited Fr8App’s benefits to the company during the difficult COVID-19 pandemic period and beyond as K-FLEX expanded its operations and approaches $1 billion in annual revenues Fr8Tech is continuing to expand its technology frontiers with the establishment of a dedicated…

WednesdayJul 05, 2023 9:00 am

The 2023 Alternative Products Expo, Dallas Chapter – “Everything Counterculture Under One Roof”

ZJ Events is proud to announce the third leg of its four-part Alternative Products Expo – the Dallas Chapter – that will be held at the Kay Bailey Hutchison Convention Center Dallas. The expo, which promises to be the ultimate event for anyone in the counterculture industry, will serve as a melting pot for everything counterculture, with featured products including CBD, mushrooms, nicotine replacement, dietary supplements, and nootropics, among others. The event will be held from July 13-15, bringing together hundreds of leading brands such as 3Chi, Mellow Fellow, and Cali Kulture. The event will also offer a platform where…

MondayJul 03, 2023 12:18 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Adds Greater Flexibility, Accelerated Technology Development Capability to NVIDIA Omniverse Platform

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently integrated its Vista-X120 Plus lidar into DRIVE Sim, an end-to-end simulation application built on the NVIDIA Omniverse platform. “The NVIDIA Omniverse platform enables real-time simulation and 3D visualization for metaverse applications by providing a shared virtual environment where users can collaborate to engineer real-world scenarios… Cepton was one of the first companies to demonstrate a 360°-coverage, dual-range lidar simulation that detected long-range obstacles and eliminated near-range blind spots. The addition of the Vista-X120 Plus into the Omniverse builds upon previous integrations to give AV developers access…

MondayJul 03, 2023 12:01 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed Formulation Results in Higher Concentration, Delivery of Estrogen Hormone than Control

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently completed its animal study HOR-A22-1, which showed that the company’s patented DehydraTECH(TM) technology platform significantly enhanced the oral delivery of the estrogen hormone estradiol. “The study found that the DehydraTECH-estradiol composition resulted in a maximum concentration in the bloodstream (‘Cmax’) of 5.65 ng/mL, which was approximately 900% higher than the control formulation’s Cmax (0.63 ng/mL). Additionally, the use of the DehydraTECH-formulation resulted in a 2,000% increase in the levels of the estrone metabolite, also measured using the Cmax parameter: DehydraTECH-estradiol resulted in a Cmax of 6.49 ng/mL…

MondayJul 03, 2023 11:30 am

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Well Positioned to Move next NanoAb Candidates into Clinical Application

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently signed an exclusive worldwide license agreement to develop and commercialize VHH antibodies (“NanoAbs”) that target Interleukin-17 (“IL-17”). “The license agreement is part of a broad-based collaboration with the Max Planck Society and the University Medical Center Göttingen (‘UMG’). The NanoAbs will be targeted toward the treatment of several relevant indications, including, but not limited to, psoriasis and psoriatic arthritis. BiondVax’s collaboration with the Max Planck Institute for Multidisciplinary Sciences and UMG, both based in Germany,…

Site Search

Company Search

Month: July 2023